Literature DB >> 9608847

Estimation of the partitioning characteristics of drugs: a comparison of a large and diverse drug series utilizing chromatographic and electrophoretic methodology.

M Hanna1, V de Biasi, B Bond, C Salter, A J Hutt, P Camilleri.   

Abstract

1-Octanol-water log P values for a large number of standards and bioactive molecules have been correlated to the logarithm of the corresponding capacity factors determined by reversed-phase high-performance liquid chromatography, using a novel dynamically coated phase, containing phosphatidylcholine. Similarly a correlation was also obtained for log P and capacity factors determined by micellar electrokinetic capillary chromatography (MECC), involving the use of phosphatidylcholine--bile acid mixed micelles in the separation buffer. Statistical analysis of data obtained via both methods has shown that either method will give reliable log P predictions, although MECC is generally more useful for neutral and basic compounds. It is recommended that, as both methods can easily be set up in an analytical laboratory, their combined use provides rapid methodology for the confident estimation of hydrophobicity, as measured by log P for the widest diversity of chemical structures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9608847     DOI: 10.1021/ac971122l

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

1.  Correlation of the capacity factor in vesicular electrokinetic chromatography with the octanol:water partition coefficient for charged and neutral analytes.

Authors:  J L Razak; B J Cutak; C K Larive; C E Lunte
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

2.  An NH2-terminal truncated cytochrome P450 CYP3A4 showing catalytic activity is present in the cytoplasm of human liver cells.

Authors:  Songhee Jeon; Keon Hee Kim; Chul Ho Yun; Boo-Whan Hong; Yoon-Seok Chang; Ho-Seong Han; Yoo-Seok Yoon; Won-Bum Choi; Soyun Kim; Ai-Young Lee
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.